Clinical Trial

BioDulse II: The Effect of an Irish Seaweed Protein Extract on Glucose Control in Adults With Type 2 Diabetes

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Co-ingesting protein with carbohydrate is an effective way to improve postprandial glucose handling. The investigators have isolated and identified a bioactive protein extracted from seaweed. The investigators aim to explore how varying doses of seaweed protein influence postprandial glycaemia and insulinaemia in a population with type 2 diabetes.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-08-03; most recent amendment 2024-04-08.
Status change: Recruiting → Active, Not Recruiting 2024-04-08
Status change: Not Yet Recruiting → Recruiting 2023-08-22
Trial Details
NCT Number NCT05986253
Lead Sponsor University of Limerick
Conditions Type 2 Diabetes
Enrollment 10 participants
Start Date 2023-08-07
Primary Completion 2031-12-31 (estimated)
Study Completion 2031-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-04-09